Wellstar Paulding Medical Center Breaks Ground on New Radiation Technology

Mary Chatman, PhD, RN, executive vice president (EVP) of Wellstar Health System and president of Wellstar Kennestone Regional Medical Center and Wellstar Windy Hill Hospital, was named chair-elect of the Board of Trustees of the Georgia Hospital Association (GHA) on Nov. 10. Chatman, who has served on the GHA Board since February 2020, will lead the Board in developing strategies for GHA hospital members, advocating for the highest quality care for patients and supporting adequate reimbursement for hospitals. 

“Mary Chatman is a visionary leader whose vast leadership skills have benefited Wellstar hospitals and the communities they serve,” said GHA President and CEO Earl Rogers. “She is a strong patient advocate and we look forward to her expertise and leadership of our Board.”  

In addition to serving as a Wellstar EVP and president of two of the system’s hospitals, Chatman oversees the operations of the seven other Wellstar hospitals. In 2020, she led the opening of Wellstar Kennestone’s new emergency department, the largest in the Southeast.  

Prior to serving in her current role, Chatman was the chief operating officer and chief nursing officer at Memorial Health University Medical Center in Savannah, where she was responsible for managing the 654-bed hospital and its nursing operations. She also served as interim chief information officer for Memorial and completed the electronic health record conversion to EPIC.  

This year, Gov. Brian Kemp appointed Chatman to the state’s Healthcare Workforce Commission, where she has helped address challenges in the hiring and retention of healthcare workers.  

Chatman has been recognized locally and nationally as a prominent leader and strong patient advocate in health care. Atlanta Daily World recognized her among the 2018 Women of Excellence. Diversity MBA Magazine named her among the 2018 Top 100 Under 50 Executive & Emerging Leaders and 2020 Top 100 Women of Influence. Profiles in Diversity Journal named her a 2020 Women Worth Watching® in STEM award winner. Chatman was recognized by Atlanta Magazine among the 2021 Women Making A Mark honorees and by Becker’s as one of the 75 Black Healthcare Leaders to Know 2022. She was also named the 2020 West Cobb Citizen of the Year for serving on the frontlines for Cobb County, fighting COVID-19 and collaborating with local leaders.   

Chatman is deeply involved in the community, serving as board member for United Community Bank and active in the fight to find a cure for type 1 diabetes. She is a member of the American Nurses Association and the American College of Healthcare Executives. She earned her Bachelor of Science, Master of Science and Doctor of Philosophy degrees from East Carolina University in Greenville, North Carolina.

Innovative technology at Wellstar is offering patients a new, minimally invasive option for lung biopsies, reducing complications and helping expedite lung cancer treatment.

The Ion system is a robotic-assisted platform for performing lung biopsies. If a lung cancer screening or any other CT scan shows a suspicious nodule, providers will need to perform a biopsy to determine if the patient has lung cancer and how to proceed with care.

“Those nodules may not be cancer, but in certain situations we still need to know what it is,” said Wellstar Pulmonologist Dr. Timothy Udoji. “The Ion technology helps us biopsy those nodules to get an answer so that additional workup can be done immediately. If it is cancer, we want to catch it at an early stage.”

The system uses a three-dimensional spatial recognition technology that helps guide a catheter down the airway, deep into the lung, all the way to small nodules where biopsies can be performed. The robotic catheter maintains its shape and stability throughout the biopsy process significantly improving diagnostic yield compared to other modalities.

“The better the image and the more certainty we have of the spatial location of the catheter, the better we can avoid complications by making sure we are not too close to a blood vessel or the edge of the lung,” said Wellstar Thoracic Surgeon Dr. Daniel Fortes.

During the biopsy, providers can also use the Ion system to mark an area in the lung, making it easier to find later during surgery.

“If something is very small and hard to find in surgery, Ion can be used to mark that area with dye, or contrast, that allows us to find it in surgery,” Dr. Fortes said. “With this technology added to the surgical robotic system in the operating room, we can better identify those lesions and remove smaller portions of lung, also called segments.”

Technology to help provide peace of mind

The Ion system also has further reach than previous technologies and is able to more easily biopsy nodules in the peripheral areas of the lung. For many cancer patients, this will allow them to initiate care earlier and improve their outcomes, as well as give them peace of mind during the treatment process.

“Mental health impacts physical health. We are able to confidently biopsy and identify these nodules and that means a lot for our patients,” Dr. Udoji said. “Now, with this new technology we are able to get a biopsy done much earlier which has huge outcome implications for malignant nodules.”

At Wellstar, cancer care is tailored for each patient. In the Wellstar STAT Clinic for Lung Cancer, patients meet with multiple specialists at once to discuss their care options and create a personalized treatment plan. Specialists in the STAT Clinics, which are located at Wellstar Cobb, Kennestone, North Fulton and West Georgia medical centers, work with patients to determine the optimal course of treatment and will talk with patients and families about biopsy options, including the Ion system. The STAT Clinics give patients the opportunity to have their diagnoses managed right away, and literature shows that the clinics’ diagnostic and treatment model improves outcomes for patients.

The Ion system is currently in use at Wellstar Kennestone Regional Medical Center. Learn more about lung cancer care at wellstar.org/lungcancer.

This recognition is a testament to the nearly 1,000 digital, technology, data, and innovation team members who help deliver on Wellstar’s mission of improving the health and well-being of every person served.